keyboard_arrow_up

Global Companion Diagnostic Technologies Market - Reports and Intelligence

Reports and Intelligence incorporates another report titled "Global Companion Diagnostic Technologies Market (Indication and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020"

The report figures the global companion diagnostic market to achieve a business sector size of $3.5 billion, enrolling a CAGR of 20% throughout 2014-2020. North America would keep on generating highest income throughout the assessment period; however, LAMEA would witness the speediest development with a CAGR of 22.7% throughout the evaluated period.

Get detailed report at:  http://www.reportsandintelligence.com/companion-diagnostic-technologies-market

Companion diagnostics help patients to perceive a specific treatments that would help them in curing their ailment; which would improve the treatment procedures and reduce healthcare costs. Further, the procedure would help to distinguish the best therapeutic treatment for patients which would chalk out ineffectual medical treatments.  Rising pool of cancer patients, personalized treatment approach and an increase in the side effects of drugs is pushing R&D to design targeted therapies. New biomarker disclosures and technological strides are helping towards the development of the CD business sector. On the other hand, an effective co-ordination of therapeutic products and companion diagnostics would be a litmus test for the business sector. In any case, the increasing incidences of cancer, central nervous system conditions and cardiovascular conditions have worked positively for the growth of CD market.

The companion diagnostics market, in terms of indication is divided into oncology, CNS, autoimmune & inflammation, cardiovascular, virology and others. At present, the maximum revenue for the companion diagnostics market is generated from oncology segment.

Breast cancer generates the highest revenue within the oncology segment.  Currently, companion diagnostics for central nervous system conditions, inflammation and autoimmune diseases, cardiovascular conditions, and viral diseases are nominal, with the majority of it in the budding stage.

Similar report at Reports and Intelligence-

Global Synthetic Biology Market - http://www.reportsandintelligence.com/synthetic-biology-market

The companion diagnostic, in terms of technology is divided into immmunohistochemistry and sub-atomic diagnostics.

The business sector is headed by North America followed, by Europe due to noteworthy cash flows in R&D, rising rates of cancer and other conditions in these regions. In any case, LAMEA is expected to develop rapidly because due rising cases of diseases.

Ten most essential firms in companion diagnostics have been assessed by the report.

 They listed below:

·          Qiagen, Dako (Agilent Technologies)

·          Abbott Laboratories, Inc.

·          Roche

·          BioMerieux

·          Myriad Genetics, Inc.

·          Leica Microsystems

·          Ventana Medical Systems

·          Life Technologies

·          Resonance Health Ltd.

 

About Us:

Reports and Intelligence is an online library for research reports in numerous sectors and their verticals. This is the one stop destination for well researched reports with exact market analysis.

We have a well known clientele lists who are master in preparing research reports. We make sure that all our clients adopt a rational and scientific approach in order to sell their reports on our webs tie. Thus, every report that we sell are well studied and based on accurate facts and figures.

 

Contact Us:

Sona Padman

5320 SW Macadam Avenue,

Suite 100, Portland, OR 97239

United States

Direct: +1 (617) 674-4143

Toll Free: +1 (855) 711-1555 (U.S. & Canada)

Fax: +1 (855) 550-5975

Email: sales@reportsandintelligence.com

Web: http://www.reportsandintelligence.com